Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3682048014 | Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682049018 | Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4589691000052117 | metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Product containing metformin and pioglitazone (medicinal product) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has active ingredient | Pioglitazone (substance) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has active ingredient | Metformin (substance) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has active ingredient | Thiazolidinedione (substance) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Metformin-containing product in oral dose form | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has basis of strength substance (attribute) | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | har täljarvärde som visar styrka | 500 | false | Inferred relationship | Some | 1 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has basis of strength substance (attribute) | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | har täljarvärde som visar styrka | 15 | false | Inferred relationship | Some | 2 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 2 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has precise active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Has precise active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Metformin- and pioglitazone-containing product in oral dose form | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Metformin and pioglitazone only product in oral dose form | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Product containing biguanide (product) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Product containing thiazolidinedione (product) | false | Inferred relationship | Some | ||
| metforminhydroklorid 500 milligram och pioglitazonhydroklorid 15 milligram, oral tablett | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR